Article
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
The New England journal of medicine - 10 Jun 2021
Hacisuleyman Ezgi, Hale Caryn, Saito Yuhki, Blachere Nathalie E, Bergh Marissa, Conlon Erin G, Schaefer-Babajew Dennis J, DaSilva Justin, Muecksch Frauke, Gaebler Christian, Lifton Richard, Nussenzweig Michel C, Hatziioannou Theodora, Bieniasz Paul D, Darnell Robert B
Abstract excerpt
Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of clinical concern. In a cohort of 417 persons who had received the second dose of BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine at least 2 weeks previously, we identified 2 women with vaccine breakthrough infection. Despite evidence of vaccine efficacy in both women, symptoms of coronavirus disease 2019 developed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
